CochLear (OTCMKTS:CHEOY) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of CochLear (OTCMKTS:CHEOY) from a strong sell rating to a hold rating in a research note released on Monday morning,Zacks.com reports.

Separately, UBS Group cut CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy”.

CochLear Price Performance

Shares of CHEOY stock opened at $39.12 on Monday. The stock’s 50 day simple moving average is $39.27 and its 200 day simple moving average is $64.35. CochLear has a twelve month low of $31.82 and a twelve month high of $105.60.

CochLear Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.